Thursday, March 01, 2018 6:26:46 PM
Since Amarantus has always been a penny stock and the OTCBB, I'd say that the value of MANF has not been that much.
Now, if it can prove itself in clinical trials, then the value of it should go up tremendously.
But the problem remains on how Geraldo will be able to get it through clinical trials considering he has an abysmal record of getting anything done in a competent fashion.
I've said it before and I'll say it again, Geraldo should put his ego in check and have someone else run the company, someone who knows how to run a start up biotech. Obvious, he won't due to said inflated ego the fact he has to earn an income.
So don't be surprised when this comes crashing down again due to the incompetency of Geraldo Conusallagain.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM